Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000758049 | SCV000564472 | benign | Cardiomyopathy | 2016-12-15 | reviewed by expert panel | curation | The filtering allele frequency of the c.5736C>T (p.Ile1912=) variant in the MYH7 gene is 0.36% (72/16512) of South Asian chromosomes by the Exome Aggregation Consortium (http://exac.broadinstitute.org), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Inherited Cardiomyopathy Expert Panel (BA1; PMID:29300372). |
Laboratory for Molecular Medicine, |
RCV000035981 | SCV000059633 | benign | not specified | 2015-06-25 | criteria provided, single submitter | clinical testing | p.Ile1912Ile in exon 39 of MYH7: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 0.4% (72/16512) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs200728597). |
Prevention |
RCV000035981 | SCV000303252 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000554421 | SCV000623752 | benign | Hypertrophic cardiomyopathy | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618874 | SCV000739921 | likely benign | Cardiovascular phenotype | 2023-07-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000035981 | SCV000862862 | likely benign | not specified | 2018-08-16 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000758049 | SCV000913857 | benign | Cardiomyopathy | 2018-10-16 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000758049 | SCV001333061 | likely benign | Cardiomyopathy | 2018-12-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529452 | SCV001842897 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529452 | SCV004129081 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | MYH7: BP4, BP7 |
All of Us Research Program, |
RCV000758049 | SCV004823471 | benign | Cardiomyopathy | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529452 | SCV001742935 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529452 | SCV001926894 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529452 | SCV001953675 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001529452 | SCV002036264 | likely benign | not provided | no assertion criteria provided | clinical testing |